Scientific Advisory Committee
Milana Dolezal, MD, MSc
Milana Dolezal, MD, MSc is a fellowship-trained hematologist oncologist board-certified in hematology, oncology, and internal medicine. She provides care at the Stanford Medicine Cancer Center in Emeryville. Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director.
W. Lawrence Drew, MD, PhD
W. Lawrence Drew, MD, PhD is the Director, Clinical Virology Laboratory and Professor of Laboratory Medicine at the School of Medicine, University of California, San Francisco. He has overseen multiple studies of cytomegalovirus infection in people with HIV, including a nationwide, 13-center collaborative study.
William D. Figg, PharmD
W. David Hardy, MD
Dr. W. David Hardy is a scientific and medical consultant focusing on developing novel vaccine and cure/remission strategies for human viral diseases. He serves as Adjunct Clinical Professor of Medicine at the Keck School of Medicine of USC. He served as Senior Director of Research at Whitman-Walker Health in Washington D.C., overseeing NIH-funded ACTG trials and HIV Cohort studies and industry-sponsored trials from 2015-2018. During that time he also held an academic appointment as Adjunct Professor of Medicine at Johns Hopkins University School of Medicine. Hardy received his M.D. from Baylor College of Medicine and completed his residency at Harbor-UCLA Medical Center. Dr Hardy currently serves as Chair of the Education Committee and member of the Executive Committee of the American Academy of HIV Medicine.